In automated peritoneal dialysis (APD), a patient's peritoneal membrane is more intensively exposed to fresh dialysate than it is in continuous ambulatory peritoneal dialysis (CAPD). Our aim was to study, in incident peritoneal dialysis (PD) patients, the influence of APD—compared with that of CAPD—on peritoneal transport over 4 years.
♦ Design, Setting, Participants, and Measurements
Patients were included if at least 2 annual standard permeability analyses (SPAs) performed with 3.86% glucose were available while the patient was using the same modality with which they had started PD (APD or CAPD). Patients were followed until their first modality switch. Differences in the pattern of SPA outcomes over time were tested using repeated-measures models adjusted for age, sex, comorbidity, primary kidney disease, and year of PD start.
♦ Results
The 59 CAPD patients enrolled were older than the 47 APD patients enrolled (mean age: 58 ± 14 years vs 49 ± 14 years; p < 0.01), and they had started PD earlier (mean start year: 2000 vs 2002). Over time, no differences in solute (p > 0.19) or fluid transport (p > 0.13) were observed. Similarly, free water transport (p = 0.43) and small-pore transport (p = 0.31) were not different between the modalities. Over time, patients on APD showed a faster decline in effective lymphatic absorption rate (ELAR: p = 0.02) and in transcapillary ultrafiltration (TCUF: p = 0.07, adjusted p = 0.05). Further adjustment did not change the results.
♦ Conclusions
Compared with patients starting on CAPD, those starting on APD experienced a faster decline in ELAR and TCUF. Other transport parameters were not different over time between the groups.
BroS., BjornerJ.B., Tofte-JensenP., KlemS., AlmtoftB., DanielsenH.A prospective, randomized multicenter study comparing APD and CAPD treatment.Perit Dial Int1999; 19: 526–33.
2.
GallarP., OrtegaO., CarrenoA., VigilA.Rate of decline in residual renal function is equal in CAPD and automated peritoneal dialysis patients.Perit Dial Int2000; 20: 803–5.
3.
HidakaH., NakaoT.Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis.Nephrology (Carlton)2003; 8: 184–91.
4.
HiroshigeK., YuuK., SoejimaM., TakasugiM., KuroiwaA.Rapid decline of residual renal function in patients on automated peritoneal dialysis.Perit Dial Int1996; 16: 307–15.
5.
HolleyJ.L., AslamN., BernardiniJ., FriedL., PirainoB.The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients.Perit Dial Int2001; 21: 302–5.
6.
HufnagelG., MichelC., QueffeulouG., SkhiriH., DamieriH., MignonF.The influence of automated peritoneal dialysis on the decrease in residual renal function.Nephrol Dial Transplant1999; 14: 1224–8.
7.
JohnsonD.W., MudgeD.W., SturtevantJ.M., HawleyC.M., CampbellS.B., IsbelN.M.Predictors of decline of residual renal function in new peritoneal dialysis patients.Perit Dial Int2003; 23: 276–83.
8.
LiaoC.T., ShiaoC.C., HuangJ.W., HungK.Y., ChuangH.F., ChenY.M.Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients.Perit Dial Int2008; 28(Suppl 3): S191–5.
9.
MoistL.M., PortF.K., OrzolS.M., YoungE.W., OstbyeT., WolfeR.A.Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol2000; 11: 556–64.
10.
SinghalM.K., BhaskaranS., VidgenE., BargmanJ.M., VasS.I., OreopoulosD.G.Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.Perit Dial Int2000; 20: 429–38.
11.
OrtegaO., GallarP., CarreñoA., GutierrezM., RodriguezI., OlietA.Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.Am J Nephrol2001; 21: 189–93.
12.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
13.
Di PaoloN., SacchiG.Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy.Perit Dial Int1989; 9: 41–5.
14.
NakayamaM., KawaguchiY., YamadaK., HasegawaT., TakazoeK., KatohN.Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.Kidney Int1997; 51: 182–6.
15.
RippeB., SimonsenO., HeimbürgerO., ChristenssonA., HaraldssonB., StelinG.Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.Kidney Int2001; 59: 348–57.
16.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
17.
SelgasR., Fernandez-ReyesM.J., BosqueE., BajoM.A., BorregoF., JimenezC.Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.Am J Kidney Dis1994; 23: 64–73.
18.
BreborowiczA., MartisL., OreopoulosD.G.Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity.Perit Dial Int1995; 15: 152–7.
19.
FusshöllerA., zur NiedenS., GrabenseeB., PlumJ.Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.J Am Soc Nephrol2002; 13: 1055–60.
20.
La MiliaV., LimardoM., CavalliA., CrepaldiM., LocatelliF.Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.Nephrol Dial Transplant2009; 24: 2894–8.
21.
Rodriguez-CarmonaA., Pérez-FontánM., Garca-NaveiroR., VillaverdeP., PeteiroJ.Compared time profiles of ultra-filtration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients.Am J Kidney Dis2004; 44: 132–45.
22.
SmitW., van DijkP., LangedijkM.J., SchoutenN., van den BergN., StruijkD.G.Peritoneal function and assessment of reference values using a 3.86% glucose solution.Perit Dial Int2003; 23: 440–9.
23.
PannekeetM.M., ImholzA.L., StruijkD.G., KoomenG.C., LangedijkM.J., SchoutenN.The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.Kidney Int1995; 48: 866–75.
24.
RenckH., LjungströmK.G., HedinH., RichterW.Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 mL dextran 1, 15%, administered before dextran 70 or dextran 40.Acta Chir Scand1983; 149: 355–60.
25.
KoomenG.C., KredietR.T., LeegwaterA.C., StruijkD.G., AriszL., HoekF.J.A fast reliable method for the measurement of intraperitoneal dextran 70, used to calculate lymphatic absorption.Adv Perit Dial1991; 7: 10–14.
26.
SmitW., StruijkD.G., Ho-Dac-PannekeetM.M., KredietR.T.Quantification of free water transport in peritoneal dialysis.Kidney Int2004; 66: 849–54.
27.
WestraW.M., SmitW., ZweersM.M., StruijkD.G., KredietR.T.Diffusion correction of sodium sieving applicable in a peritoneal equilibration test.Adv Perit Dial2003; 19: 6–9.
28.
Ho-dac-PannekeetM.M., HiralallJ.K., StruijkD.G., KredietR.T.Longitudinal follow-up of CA125 in peritoneal effluent.Kidney Int1997; 51: 888–93.
29.
AkmanS., van WestrhenenR., De WaartD.R., HiralallJ.K., ZweersM.M., KredietR.T.The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.Adv Perit Dial2003; 19: 24–7.
30.
ImholzA.L., KoomenG.C., StruijkD.G., AriszL., KredietR.T.Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD.Kidney Int1993; 43: 1339–46.
31.
KredietR.T., ZemelD., StruijkD.G., KoomenG.C., AriszL.Individual characterization of the peritoneal restriction barrier to macromolecules.Adv Perit Dial1991; 7: 15–20.
32.
ZemelD., KredietR.T., KoomenG.C., StruijkD.G., AriszL.Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD.Perit Dial Int1991; 11: 217–23.
33.
BadveS.V., HawleyC.M., McDonaldS.P., MudgeD.W., RosmanJ.B., BrownF.G.Automated and continuous ambulatory peritoneal dialysis have similar outcomes.Kidney Int2008; 73: 480–8.
34.
MehrotraR., ChiuY.W., Kalantar-ZadehK., VoneshE.The outcomes of continuous ambulatory and automated peritoneal dialysis are similar.Kidney Int2009; 76: 97–107.
35.
MichelsW.M., VerduijnM., BoeschotenE.W., DekkerF.W., KredietR.T.Similar survival on automated peritoneal dialysis and continuous ambulatory peritoneal dialysis in a large prospective cohort.Clin J Am Soc Nephrol2009; 4: 943–9.
36.
ImholzA.L., KoomenG.C., VoornW.J., StruijkD.G., AriszL., KredietR.T.Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.Nephrol Dial Transplant1998; 13: 146–53.
37.
MichelsW.M., ZweersM.M., SmitW., KorevaarJ., StruijkD.G., van WestrhenenR.Does lymphatic absorption change with the duration of peritoneal dialysis?Perit Dial Int2004; 24: 347–52.
